Summary We have investigated the oestrogen receptor (ER) status of 20 cervical adenocarcinomas by immunocytochemistry for ER protein and non-isotopic in situ hybridisation for ER mRNA. Both methods, which are applicable to paraffin sections, were developed and validated in breast carcinomas with known ER content. Six cervical adenocarcinomas contained immunocytochemically demonstrable ER protein; all contained ER mRNA, but staining was less intense in poorly differentiated areas of four tumours. This disparity between protein and mRNA detection needs further investigation as does the possibility that oestrogens may play a role in the pathogenesis of cervical adenocarcinoma.
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Adenocarcinoma of the cervix is a relatively rare tumour which is increasing in incidence among young women (Peters et al., 1986; Schwartz & Weiss, 1986; Chilvers et al., 1987) . Little is known of its aetiology and pathogenesis.
The cervix, like the breast, is a target tissue for oestrogens and progesterone. This is shown by menstrual cycle related alterations in the quality of cervical mucus (Wakefield & Wells, 1985) , and the demonstration of oestrogen and progesterone receptors in the normal cervix (Kupryjanczyk & M6ller, 1988; Cano et al., 1990; Nonogaki et al., 1990) . While the clinical and biological significance of oestrogen receptor status in breast carcinoma has been extensively studied, very little factual information is available on the presence of oestrogen receptors in cervical adenocarcinoma.
Having validated our methodology in a series of breast carcinomas with known ER protein content, we studied ER mRNA and protein content of 20 cervical adenocarcinomas.
Materials and methods

Immunocytochemistry
All tissues were fixed in 10% formol saline and embedded in paraffin wax. Five ym sections were dewaxed, rehydrated and immunostained using a modification of an avidinbiotin-peroxidase complex technique for detection of ER (Andersen et al., 1986; Cheng et al., 1988) . After blocking endogenous peroxidase activity the sections were digested at 37°C in a 0.02% Pronase E (Sigma, P6911) solution for 20-30min. The washed slides were incubated with normal swine serum, followed by application of anti-ER monoclonal antibody (H222) or control antibody (rat IgG) overnight at room temperature. After washing, the slides were incubated at room temperature with biotinylated sheep anti-rat IgG (Amersham) for 30 min, and avidin-biotin complex (Dako) for 1 h. The reaction was developed with diaminobenzidine. The staining was intensified by immersing the slides for 10 min in 0.5% CuSO4 in 0.85% NaCl. Counterstaining was performed with 1% methylgreen.
In situ hybridisation A 24 base cDNA oligonucleotide probe (5' CTC CAG CTC GTT CCC TTG GAT CTG 3') complementary to human (Green et al., 1986; Pelletier et al., 1988; Ponglikitmongkol et al., 1988; Graham et al., 1991) . The probe was labelled at the 5' end with digoxigenin-l 1-UTP and purified by HPLC. A 25 base oligoprobe complementary to human thyroglobulin mRNA, also 5' labelled with digoxigenin-ll-UTP and synthesised to our specifications (British Bio-technology Ltd.), was used as an irrelevant control probe.
A standard in situ hybridisation method was used (Farquharson et al., 1990) . All solutions were rendered RNAse free by sterilisation and treatment with diethylpyrocarbonate.
The rehydrated sections were preincubated for 30 min in 0.2 M HCI and 15 mg ml-' Proteinase K. After prehybridisation in hybridisation buffer containing 47% formamide for 1 h at 37°C, the sections were hybridised overnight at 42°C with 1 ng ml-' ER oligoprobe. Control sections were incubated in hybridisation buffer containing 0.75 ng ml-' thyroglobulin probe. Additional control sections were digested by RNAse A 1 mg ml-' for 1 h at 37°C prior to hybridisation, and others were hybridised in the absence of labelled probe.
After hybridisation, sections were washed in graded concentrations of standard sodium citrate and incubated with an alkaline phosphatase linked antidigoxigenin antibody (Boehringer Mannheim). The reaction was developed by overnight incubation with 0.16 mg ml' bromochloro-indoylphosphate and 0.33 mg ml-' nitroblue tetrazolium.
Tumours studied
Nine breast carcinomas were selected to represent a range of ER status as measured by enzyme immunosorbent assay (EIA). This group included three breast carcinomas with no detectable ER, three with high (> 300 fmol mg cytosol liquidised tissue) and three with intermediate (43-100 fmol mg-1) ER levels.
We used archival material from 20 adenocarcinomas of the cervix from patients for whom follow-up was available. The tumours were selected to represent various morphological subtypes and grades of differentiation, and comprised 15 tumours of endocervical type, 3 clear cell carcinomas, 1 endometrioid carcinoma and 1 tumour of mixed endocervical/intestinal differentiation.
Results
Positive staining for ER protein was denoted by brown intranuclear staining while ER negative nuclei stained pale green. ER mRNA was demonstrable as dark blue cytoplasmic staining. The sections were evaluated without prior knowledge of the biochemical status of these tumours and the presence or absence of staining assessed subjectively. The heterogeneity or otherwise of staining pattern was also noted.
Immunocytochemical staining was abolished when ER antibody was replaced by control antibody. Cytoplasmic mRNA staining was greatly diminished or abolished by preincubation with RNAse. No staining was seen when the ER probe was replaced by the control thyroglobulin probe or when the test probe was omitted.
Breast carcinomas All three breast carcinomas with a high ER status by EIA showed strong positive staining for ER protein in the majority of tumour nuclei and strong cytoplasmic staining for ER mRNA (Figure 1) Cervical adenocarcinomas Six of 20 cervical adenocarcinomas were ER positive on immunocytochemistry ( Figure 2) ; in five tumours ER protein was demonstrated in the majority of epithelial nuclei throughout the tumour, while one tumour showed focal staining. There was no relationship between ER immunoreactivity and morphological subtype of tumour; all ER positive tumours were well or moderately differentiated. Cervical stromal fibroblasts and smooth muscle cells were consistently strongly ER positive. Normal endocervical epithelial cells showed variable ER positivity.
All the cervical adenocarcinomas were positive for ER mRNA (Figure 3 ) while morphologically normal endocervical epithelium was negative (Figure 4 ). Four cervical adenocarcinomas showed an heterogeneous staining pattern with reduction of mRNA staining in poorly differentiated areas. Cervical stromal fibroblasts and smooth muscle cells showed consistent cytoplasmic positivity. (range 5-144) , while five patients died of the disease (mean 11.6 months; range 2-28 months) and another died of treatment complications. All six patients whose tumours contained immunocytochemically demonstrable ER protein remained disease free on follow-up for a mean of 43.5 months. Three of four patients with cervical adenocarcinomas showing a heterogeneous staining pattern for ER mRNA died of the disease within a mean of 9 months (range 2-15) of presentation, the fourth was alive and disease free at 14 months. In contrast, of 16 patients with tumours showing diffuse ER mRNA staining, only two died of the disease.
Discussion
Oestrogen receptor status has been found to be a useful indicator of prognosis and response to endocrine manipulation in breast carcinoma. Like the breast, the uterine cervix is a target tissue for steroid hormones and contains oestrogen receptors in endocervical epithelium, stromal cells and basal layers of squamous epithelium (Kupryjanczyk & Moller, 1988; Cano et al., 1990; Nonogaki et al., 1990) . In this preliminary study we have shown, as far as we are aware for the first time, that a proportion of cervical adenocarcinomas also contain immunocytochemically detectable ER protein; this finding was associated with a good prognosis. We have further demonstrated that cervical adenocarcinomas contain ER mRNA a heterogeneous staining pattern for which was associated with a poor prognosis.
Previous studies using the dextran coated charcoal method (Martin et al., 1978; Ford et al., 1983; Gao et al., 1983;  (Nonogaki et at., 1990) none of the six cervical adenocarcinomas examined showed ER immunoreactivity.
All 20 tumours in our study showed cytoplasmic mRNA staining while only six contained immunocytochemically detectable ER protein. Thus there was an imbalance between ER mRNA and protein detection in cervical adenocarcinomas. Comparable findings have been reported for ER protein and mRNA in breast carcinomas (Graham et al., 1991) , and calcitonin peptide and mRNA in medullary carcinomas of the thyroid (Boultwood et al., 1990) . In contrast to the cervical adenocarcinomas, we found no demonstrable ER mRNA in normal endocervical epithelium which nevertheless did contain immunoreactive ER protein. Similarly, little or no calcitonin mRNA staining was found in normal thyroid C cells which contain abundant calcitonin peptide (Boultwood et al., 1990) . The paucity ofmRNA in normal tissues may be explained by the relatively low turnover of protein or peptide under physiological conditions while the relative excess ofmRNA in neoplasms may be caused by increased stability ofmRNA in tumours, increased protein breakdown, or structural abnormalities in mRNA which interfere with protein production. Existing evidence provides examples of all these possibilities. For instance, increased stability of c-myc mRNA has been observed in Burkitt's lymphoma (Eick et al., 1985) . In the human papillomavirus (HPV) containing HeLa cervical carcinoma cell line, increased protein breakdown is thought to account for the absence of p53 protein in the presence of translatable p53 mRNA (Matlashewski et al., 1986; Scheffner et al., 1990) . Finally, several variant forms of ER mRNA and protein have been described (Murphy, 1990; Fuqua et al., 1991) which do not affect the region probed in our study,but which may lead to the production of an abnormal ER protein which cannot be detected by the standard antibody. The present study provides no insight as to which of these possible mechanisms are responsible for the disparity between ER mRNA and protein detection in cervical adenocarcinoma.
The oestrogen receptor is a complex protein the physiology and pathology of which remain to be fully elucidated. However, empirical detection of ER protein has provided an insight into the pathogenesis of breast carcinoma and useful guidance in its management. The findings of this preliminary study raise the possibility that oestrogens may play a comparable pathogenetic role in some cervical adenocarcinomas and that anti-oestrogen therapy may be useful in a proportion of these tumours.
We thank Dr R.I. Nicholson for information regarding the biochemical ER levels on our series of breast carcinomas and Dr J Gee for technical advice with ER immunocytochemistry. 
